𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Castleman's disease in poems syndrome with elevated interleukin-6

✍ Scribed by Raúl N. Mandler; Daniel P. Kerrigan; Joanne Smart; Wietse Kuis; Peter Villiger; Martin Lotz


Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
949 KB
Volume
69
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Kaposi's sarcoma herpesvirus–associated
✍ Dong-Eog Kim; Ho Jin Kim; Young A. Kim; Kwang-Woo Lee 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 2 views

The pathogenic link between POEMS (polyneuropathy, organomegaly, endocrinopathy, M protein, skin changes, and various other clinical signs) syndrome and Castleman's disease is unclear. Roles for M protein in POEMS syndrome and cytokines in systemic manifestations of multicentric Castleman's disease

Systemic Castleman's disease in associat
✍ Marsh, Johnathan H. ;Colbourn, Donald S. ;Donovan, Virginia ;Staszewski, Harry 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB

## Abstract Systemic Castleman's disease is a lympho‐proliferative disorder which has been associated with autoimmune phenomena. We report a case of the plasma cell variant of Castleman's disease that was associated with autoimmune hemolytic anemia and autoimmune thrombocytopenia (Evan's syndrome),

Elevated levels of tumor necrosis factor
✍ Winter, Stuart S.; Howard, Thad A.; Ritchey, A. Kim; Keller, Frank G.; Ware, Rus 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 553 KB

Castleman's disease (CD) is a lymphoproliferative disorder characterized by enlarged hyperplastic lymph nodes. CD may be localized or multifocal, and is often associated with signs and symptoms of generalized inflammation. The systemic manifestations of CD have been previously attributed to an overp

Increased levels of circulating interleu
✍ Angela Gause; Rotraud Scholz; Sigrid Klein; Wolfram Jung; Volker Diehl; Hans Tes 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 458 KB

## Abstract Expression of interleukin‐6 (IL‐6) and IL‐6 receptors has been demonstrated in Hodgkin and Reed‐Sternberg (H and RS) cells __in vitro__ and __in vivo__. In order to evaluate the clinical significance of IL‐6 serum levels in patients with Hodgkin's disease (HD), we tested the sera of 56